Controversy has surrounded Gilead and their Veklury (remdesivir) product as the World Health Organization (WHO) Solidarity trial revealed no benefit to COVID-19 patients as reported…
Paul Elias Alexander, PhD Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. The thesis…
Contract research organizations (CROs) must increasingly not only embrace decentralized clinical trial delivery models but also increasingly innovate to provide biopharmaceutical company sponsors ever more…
The COVID-19 vaccines are necessary and key to overcoming this pandemic. TrialSite, a data- and science-driven platform, reports continually on the correlation of reduced hospitalization…
Thought the COVID-19 pandemic was on its way out as summer approaches? Think again, as at least in Russia, the pandemic enters its third wave…
For 20 days, Dr. Alan Bain of Chicago drove to Elmhurst Hospital, usually after a full work day, to administer ivermectin to a critically ill…
Apparently, the pandemic’s driven record enrollment of beneficiaries in Medicaid programs across the 50 states of the U.S.A. The national emergency led to a swelling…
Glenmark Pharmaceuticals (Glenmark), a leading generic drug producer in India, actively markets an authorized generic antiviral drug targeting COVID-19 called Favipiravir. This drug was authorized first…
TrialSite recently reported that despite apparent success with the national ivermectin protocol in India—such as a dramatic turnaround of cases in Uttar Pradesh—the World Health Organization (WHO)…
Duke University’s School of Medicine recently launched the Center for Virtual Imaging Trials (CVIT) thanks to a five-year grant from the National Institutes of Health…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
